Together We Can...
|
|
/
- 1
- 2
- 3
- 4
- 5
We are delighted and honoured to be the first customer for the MeridianIT PowerAI Vision platform, powered by IBM. This will enable OCB to dramatically speed up the development and commercialisation of precision tools to advance standards of care in personalised medicine for cancer. Vivolution has been fundamental in creating this collaboration with IBM and MeridianIT and to help solve a global healthcare challenge
David Browning
CEO / Oxford Cancer Biomarkers
- 1
- 2
- 3
- 4
- 5
/
- 1
- 2
- 3
- 4
- 5
The Vivolution team has been of great support, primarily through a number of funding clinics, but also by facilitating introductions to the Business Gateway, LINC, SIB and other key players in the start-up funding environment. The team has always been available and provided a clear overview of the funding landscape in Scotland and I would like to thank the team for their friendly and expert contribution. At BLK we are now proud of having been selected among the top 50 tech start-up in the UK and we will be pitching for £0.6m at the EIE showcase investor event in October 2020.
Gabriele Dado
CEO / BLK Global
- 1
- 2
- 3
- 4
- 5
/
- 1
- 2
- 3
- 4
- 5
It’s still early days but we now have an open dialogue with IBM on a collaboration re an Enterprise API we’re seeking to build. That wouldn’t have happened without the showcase event that Vivolution organised.
Steve Tigar
CEO / Money Dashboard
- 1
- 2
- 3
- 4
- 5
/
- 1
- 2
- 3
- 4
- 5
Vivolution has provided critical help when Ocyan was first opening in Scotland, by providing us with the key network that we needed to bootstrap. The company also supported Ocyan with navigating the numerous grant funding options available within Scotland as well as the Innovate UK programme of funding and introductions to IBM
Evangelos Pappas
CEO / Ocyan Cloud
- 1
- 2
- 3
- 4
- 5
/
- 1
- 2
- 3
- 4
- 5
The Vivolution team have facilitated 2 key events over the past 18 months which have involved the Scottish Investment Bank (SIB) Portfolio and Financial Readiness Teams:
• An investment workshop with 12 Fintech’s, 8 Scottish Angel Syndicate investors and the SIB team to discuss Investor appetite for Fintech’s, Fintech Investment propositions and investor readiness.
• An event with IBM in London giving 9 Scottish Fintech’s an opportunity to meet with IBM Financial Services Architects, large Financial ServicesCompanies and a number of London based VC investors.
• By facilitating these events, the Vivolution team has demonstrated their wide and diverse network of investors, financial services companies and Corporates within the UK and at the same time their deep understanding of the Fintech sector as they have also referred a number of qualified Fintech’s into the SIB pipeline of potential investee companies.
• An investment workshop with 12 Fintech’s, 8 Scottish Angel Syndicate investors and the SIB team to discuss Investor appetite for Fintech’s, Fintech Investment propositions and investor readiness.
• An event with IBM in London giving 9 Scottish Fintech’s an opportunity to meet with IBM Financial Services Architects, large Financial ServicesCompanies and a number of London based VC investors.
• By facilitating these events, the Vivolution team has demonstrated their wide and diverse network of investors, financial services companies and Corporates within the UK and at the same time their deep understanding of the Fintech sector as they have also referred a number of qualified Fintech’s into the SIB pipeline of potential investee companies.
Gary Torbett
Head of Financial Readiness / Scottish Investment Bank
- 1
- 2
- 3
- 4
- 5
/
- 1
- 2
- 3
- 4
- 5
We at Oxx highly value our relationship with Vivolution. They have opened up their network connectivity with early stage investment opportunities in Scotland to us - a network they have spent many years cultivating. As a result, we have met with several potential investee companies. We have also had the pleasure of attending Vivolution hosted events in Edinburgh, which have been valuable opportunities to connect with other financing partners interested in developing Scottish investment opportunities. We look forward to continuing to work with the great team at Vivolution to source opportunities to invest in Scottish businesses.
Richard Anton
General Partner / OXX.VC
- 1
- 2
- 3
- 4
- 5
/
- 1
- 2
- 3
- 4
- 5
The Vivolution team has an extensive understanding of the pains of their Fintech client portfolio and the angel investment market in Scotland and have been very effective at qualifying potentially investable Fintech’s. Vivolution has supplied a large number of qualified referrals to our Case Managers in the West and East of Scotland over the past 2 years, which LINC Scotland would have been unlikely to source directly.
David Grahame
CEO / LINC Scotland
- 1
- 2
- 3
- 4
- 5
/
- 1
- 2
- 3
- 4
- 5
The team at Vivolution have been an invaluable resource providing key insights and numerous relevant introductions to Fintech companies. They are my go-to resource for Fintech/FS as they are extremely well networked and highly responsive with requests leading to at least 5 Fintech companies currently applying for funding in excess of €2m through our annual call. Thanks Vivolution for all you have done to support EIT Digital in our first year of operation in Scotland.
Dr Martin Beaton
EIT Digital Satellite Manager / Edinburgh
- 1
- 2
- 3
- 4
- 5
/
- 1
- 2
- 3
- 4
- 5
The Vivolution team has referred a number of qualified Fintech’s to our business support services in Glasgow. The team have an in depth knowledge and understanding of the Fintech sector and I use Vivolution as a sounding board and resource for all matters related to Fintech.
Greig Sinclair
Business Advisor / Business Gateway Glasgow
- 1
- 2
- 3
- 4
- 5
/
- 1
- 2
- 3
- 4
- 5
By attending the Scottish Investment Bank workshop with Scottish Angel investors in November 2018, 2 Network Integrator funding clinics and the EIE 2019 investment event, the Vivolution consultants ensured that the Hatch AI management team was made aware of all potential avenues of funding to develop and grow our company over the next 18 months. Throughout our funding and investment journey, the Vivolution team was very pro-active with their approach to supporting Hatch AI by ensuring that they were funding and investor ready.
If we had not engaged with Vivolution and secured their invaluable support and guidance then Hatch AI would have found it very difficult to secure equity investment of £520k from Scottish Investment Bank, Business Angel Syndicates - Tri-cap and Wallace Equity, and Old College Capital as well as loan and grant funding from Scottish Edge and a Scottish Enterprise SMART feasibility grant.
If we had not engaged with Vivolution and secured their invaluable support and guidance then Hatch AI would have found it very difficult to secure equity investment of £520k from Scottish Investment Bank, Business Angel Syndicates - Tri-cap and Wallace Equity, and Old College Capital as well as loan and grant funding from Scottish Edge and a Scottish Enterprise SMART feasibility grant.
Joseph Twigg
CEO / Hatch AI
- 1
- 2
- 3
- 4
- 5
/
- 1
- 2
- 3
- 4
- 5
It has been a pleasure to work with the Vivolution team over the past two years. The team has supported a couple of workshops with FinTech companies that I have hosted at the University, demonstrating insights into and the vibrancy of Scotland’s FinTech sector and Vivolution’s role in this space. Vivolution has also supported my MBA teaching in business-to-business marketing, this year helping arrange a project with Amiqus. It is vital for our students that they can participate in our business sectors and contribute in some way to the development of companies. The Vivolution team has played a critical role in helping the business school align a range of its activities, across research and teaching, with the business, technological and organisational requirements of the FinTech sector, which we all appreciate is critical to the further economic development of the Scottish economy.
John Finch
Head of School & Professor of Marketing / Adam Smith Business School, University of Glasgow
- 1
- 2
- 3
- 4
- 5
/
- 1
- 2
- 3
- 4
- 5
Vivolution have engaged with us on several fronts; for example intros they have made plus, the thorough preparation leading up to the IBM event in London and the opportunity to meet with IBM FS architects/client execs, new VC’s and FS institutions - all of which we could not have done on our own. We were also invited to a meeting with SIB and Scottish Investors where we had the opportunity to share a few ideas on what was required around investment for Fintechs. There has also been an opportunity to explore how Fintech Scotland / SDI could support us by establishing a US fintech hub and to leverage contacts and in-country networks. One specific approach which has been discussed, relates to an open banking initiative to help SDI engage with the new wave of global payment providers and to consider Scotland as a base for their open banking venture into the UK; whilst creating an opportunity for Fintechs such as DirectID to enter into agreements with the same payment firms. Vivolution have always shown an interest to explore new and innovative commercialisation models to help Fintechs explore wider opportunities across international markets.
James Varga
CEO / DirectID
- 1
- 2
- 3
- 4
- 5
/
- 1
- 2
- 3
- 4
- 5
The Vivolution team have been an invaluable and trusted resource to FinTech Scotland and built a close working relationship over the duration of the Network Integrator contract. They helped us drive tangible outcomes, engaging with FS institutions, Professional Services Firms, Global Technology Providers and Investors which resulted in significant benefits to the wider Fintech Cluster. We look forward to continue working with Vivolution as they independently shape bespoke projects to support Industry, Academia, Investors and Fintech Scale-Ups as a Fintech Venture Builder.
Stephen Ingledew
CEO / FinTech Scotland
- 1
- 2
- 3
- 4
- 5
- 0
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
What we do
Commercial Innovation Partners who talk the language of start-ups and investors; specialising in growing emerging technology scale-ups operating in the IBM Partner Cloud and reaching customers who many only dream of.
Shaping healthtech, fintech & insurtech ideas in to viable business models in collaboration with strategic partners;
based on a lean startup and evidence based entrepreneur approach.
Shaping healthtech, fintech & insurtech ideas in to viable business models in collaboration with strategic partners;
based on a lean startup and evidence based entrepreneur approach.
WHO ARE WE?
Team of Business Advisers, with a 360 degree approach to SaaS business models, securing investment and routes-to-market
|
WHY ARE WE DIFFERENT?
Accustomed to rolling up our sleeves, talking the language of start-ups and Corporates; delivering results to your bottom line
|
WHY CHOOSE VIVOLUTION?
Emerging technology advocates with a proven track record of delivering success across domestic &
International markets |
A word from the founder
|
Mark RogerMark has worked at director level within the technology sector for over 15 years, with a background in commercialisation of Software technology companies. He has experience and expertise in SaaS business modelling, investment strategy, growth funding and wholesale business change. Mark has led M&A activity for a global software acquisition vehicle, led a technology investment fund and currently acts as director and non exec director for several tech start-ups.
|
"At IBM it's our objective to help bring solutions to market that improve health outcomes for patients. Working with likes of Vivolution, our Commercialisation Partner is critical to achieve this. Vivolution work with qualified scale-up’s and have not only introduced Oxford Cancer Biomarkers but continue to develop and support the relationship with IBM and Meridian IT. This collaboration showcases the potential of IBM’s platforms, including IBM PowerAI Vision, to support the rapid development and implementation of disruptive precision medicine innovation and resonates strongly with our focus on improving both the scope and quality of advanced personalised healthcare.”
Andreas Haimbock-Tichy, Director; Health & Life Sciences
